<DOC>
	<DOCNO>NCT01294618</DOCNO>
	<brief_summary>The aim study demonstrate safety efficacy combination 2 treatment show efficacy Chronic Phase Chronic Myelogenous Leukemia ( CP CML ) separately , never combine date , combination expect substantially increase molecular response rate .</brief_summary>
	<brief_title>Nilotinib + Pegylated Interferon Alpha 2a Untreated Chronic Phase Chronic Myelogenous Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Leukemia , Myeloid , Chronic-Phase</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>Performans status 02 CP CML diagnose since less 3 month without previous Tyrosine Kinase Inhibitor ( TKI ) interferon treatment Adequate organic function : Total Bilirubin &lt; 1.5xUpper Normal Range ( UNR ) . Aspartate Amino Transferase ( ASAT ) Alanine Amino Transferase ( ALAT ) &lt; 2.5xUNR . Alkaline phosphatase ≤ 2.5xUNR Amylase lipase ≤ 1.5xUNR . Creatininemia &lt; 1.5xUNR . Biological blood standard : Potassium ≥ Lower Normal Range ( LNR ) Magnesium ≥ LNR . Phosphorus ≥ LNR Calcium ≥ LNR . Negative pregnancy test within last 7 day woman childbearing potential . Informed consent sign Compliance tretament ensure , Valid social insurance Prior TKI interferon treatment CML Contraindication IFN Pregnancy , breast feeding Human Immunodeficiency Virus positive , chronic hepatitis B C. Other BCRABL transcript Mbcr Cardiopathy define : Left Ventricular Ejection Fraction ( LVEF ) &lt; 45 % . Left bundle branch block Ventricular pacemaker . Congenital prolong QT Past ventricular significant auricular tachyarrythmia Clinically significant bradycardia ( &lt; 50 per minute ) . QTc ( Fredericia ) &gt; 450 m ( average 3 Elektrokardiogramm ( EKG ) ) . Myocardial infarction last 12 month . Unstable angina within last 12 month . Other significant cardiac disease . Other uncontrolled severe disease ( diabetes melittus etc… ) Other ongoing malignant disease . Past history congenital acquire clinically significant bleed disorder . Previous radiotherapy ≥25 % bone marrow . Serious surgery within past 4 week Investigational treatment within last 30 day prior day 1 . History non compliance . Cytochrome P450 3A4 ( CYP3A4 ) inhibitor could withdraw modify ( erythromycin , ketoconazole , itraconazole , voriconazole , clarithromycin , telithromycin , ritonavir , mibefradil ) . Severe gastrointestinal disorder ( gastric ulcer , uncontrolled nausea , malabsorption syndrome , small intestine resection , gastric shunt ) . Hepatic , renal pancreatic chronic disorder unrelated CML Recent history acute pancreatitis within year history chronic pancreatic disease . Any concommittant treatment induce QT prolongation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Chronic Myelogenous Leukemia</keyword>
	<keyword>nilotinib</keyword>
	<keyword>pegylated interferon</keyword>
	<keyword>BCR-ABL Philadelphia chromosome</keyword>
	<keyword>Hematologic , cytogenetic molecular response rate kinetics studied addition safety combination</keyword>
</DOC>